clinicaltrials.gov
ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS kanalas
Gaukite naujausius ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days atnaujinimus iškart, kai jie pasirodo.
Naujausi įrašai
Skaitykite ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days ten, kur skaitote kitus šaltinius
Žmonės, sekantys ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days, taip pat seka
-
Bristol Myers Squibb Press Releases news.bms.com
-
What's new ema.europa.eu
Klausimai
Koks yra ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS kanalo URL?
Kanalo adresas yra https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=pegfilgrastim+neutropenia&recrs=abdef&type=Intr&phase=0124&fund=2&count=10000. Įklijuokite jį į bet kurią RSS skaityklę arba spustelėkite Sekti dabar, kad skaitytumėte per Feeder.
Kaip dažnai ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days skelbia įrašus?
ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days skelbia įrašus rečiau nei kartą per savaitę. Paskutinis įrašas paskelbtas prieš 2 dienos.
Ar ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS kanalas veikia?
Taip. Feeder patikrino jį prieš 13 minučių, o kanalas atsakė be klaidų.
Apie ką rašo ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?
Feeder priskiria jį šioms temoms: Sveikata.
Kaip sekti ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days per Feeder?
Spustelėkite Sekti dabar ir, jei dar neturite paskyros, užsiregistruokite. Nemokamas Feeder planas apima iki 200 srautų ir veikia žiniatinklyje, iPhone bei Android įrenginiuose. Kredito kortelės nereikia.
Sekite ClinicalTrials.gov: pegfilgrastim neutropenia | Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days per Feeder
Nemokamas Feeder planas apima iki 200 srautų ir veikia žiniatinklyje, iPhone bei Android įrenginiuose. Kredito kortelės nereikia.